Abstract
Antimicrobial photodynamic therapy has become an important component in the treatment of human infection. This review considers historical guidelines, and the scientific literature to envisage what future clinical guidelines for treating skin infection might include. Antibiotic resistance, vertical and horizontal infection control strategies and a range of technologies effective in eradicating microbes without building up new resistance are described. The mechanism of action of these treatments and examples of their clinical use are also included. The research recommendations of NICE Guidelines on the dermatological manifestations of microbial infection were also reviewed to identify potential applications for PDT. The resistance of some microbes to antibiotics can be halted, or even reversed through the use of supplementary drugs, and so they are likely to persist as a treatment of infection. Conventional PDT will undoubtedly continue to be used for a range of skin conditions given existing healthcare infrastructure and a large evidence base. Daylight PDT may find broader antimicrobial applications than just Acne and Cutaneous Leishmaniasis, and Ambulatory PDT devices could become popular in regions where resources are limited or daylight exposure is not possible or inappropriate. Nanotheranostics were found to be highly relevant, and often include PDT, however, new treatments and novel applications and combinations of existing treatments will be subject to Clinical Trials.
Graphical abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs43630-021-00169-w/MediaObjects/43630_2021_169_Figa_HTML.jpg)
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
The aim of this review is to describe why antimicrobial Photodynamic therapy (aPDT) has become an important component in the treatment of human infection and to discuss what future guidelines for its clinical application might include. The emergence of antibiotic resistance has been considered, as have vertical and horizontal infection control strategies [1], and a range of technologies effective in eradicating microbes without building up new resistance. The mechanism of action of these technologies is described and examples of their clinical use summarised. Finally, national and international clinical guidelines on the manifestations of microbial infection and the use of PDT have been studied, including their research recommendations. While consensus on the use of antimicrobial PDT in humans is the ultimate focus of this review, it is first acknowledged that: the methods were developed in the laboratory; [2] many of the basic science investigations were done on murine cohorts; [3] current veterinary indications for PDT are broad ranging and include bacterial infection in domestic animals [4].
Antibiotics were clinically introduced during the Second World War and the emergence of resistant strains of bacteria was described as early as 1959 [5] followed by a detailed study of the underpinning mechanisms revealing several modes of resistance. Innate immunity to specific antibiotics exists in microbes because of impenetrable cell membranes, active cell efflux, and/or the presence of certain gene alleles in specific positions on the chromosome creating a resistant phenotype [6]. These mechanisms pre-date the use of antibiotic drugs [6]. Extrinsic resistance is an acquired property evolving via mutation, or during experimental recombination [7], when antibiotics are used at subinhibitory concentrations causing recombination [8], or via horizontal transfer of r-genes [9].
Methods of tracing the evolution of microbial strains have been described including phylogenetic trees [10]—retrospective by nature—and prospective in-vivo measurements of the natural course of the nosocomial bacterial infection becoming resistant to a series of antibiotics [11]. Nanotheranostics offers additional insights by allowing observation of microbes in-situ, [12] and during treatment.
During the Covid-19 pandemic, infection prevention and control in public places and healthcare has been enhanced [13,14,15,16] to minimise the proliferation of the virus. However, antimicrobial stewardship has diminished [17, 18] with the net effect likely to be a worldwide increase in microbial resistance. In their 2010 paper, Davies and Davies [19] highlight the presence of multidrug-resistant bacteria in the biosphere with consequences aggravated by civil unrest, violence, famine, natural disaster and poor hospital practices; and so the net long-term effects of Covid-19 on bacteria, and indeed other microbes, has yet to be realised. Multiple and extreme (a lack of susceptibility to four or more drugs) antibiotic resistance has necessitated the use of alternative treatment methods for microbial infection including electroporation [20]; antimicrobial peptides (AMPs) [21]; photodynamic therapy (PDT) [22]; photothermal therapy [23]; nitrous oxide (NO) releasing nanoparticles [24]; cannabidiol [25]; or combinations of therapies. Electroporation is a technique where 30–100 V pulses are used for a fraction of a second to create local aqueous permeable regions in between lipid membranes by destabilisation [26], however, its clinical importance have yet to be tested. Accessibility and limitations on sensitivity and specificity of PDT has been addressed by conjugation of known photosensitisers to cationic molecules, AMPs, antibodies, targeted antibiotics or nanomaterials [27,28,98] and antibiotics [31]; with adjunct illumination to modulate antibiotic function or monitor progress in bacterial eradication [12]; simultaneous PDT, PTT and bioluminescence [99]; the management of sepsis [100]. Conventional PDT will undoubtedly play a part given its large evidence base and existing healthcare facilities and infrastructure—It may be the only treatment necessary for some cases of Acne vulgaris and related scarring. Daylight PDT and the use of ambulatory devices could become more popular in regions where resources are limited, with a broader scope than just CL and Acne Vulgaris—subject to high-quality evidence. In theory, the resistance of microbes to antibiotics is reversible, and in practice it is possible that new resistance could at least be halted by the use of supplementary drugs. Antibiotics are therefore unlikely to become obsolete.
Data availability
As there was no data collected for this review, data cannot be made available.
Code availability
There was no code written during this study, and so code cannot be made available.
References
Abbas, S. M., Doll, M., & Stevens, M. P. (2018). Vertical versus horizontal infection control interventions. In G. Bearman, S. Munoz-Price, D. Morgan, & R. Murthy (Eds.), Infection prevention. Cham: Springer. https://doi.org/10.1007/978-3-319-60980-5_18
Spikes, J. D. (1985). The historical development of ideas on applications of photosensitized reactions in the health sciences. In R. V. Bensasson, G. Jori, E. J. Land, & T. G. Truscott (Eds.), Primary photo-processes in biology and medicine. Boston: Springer. https://doi.org/10.1007/978-1-4684-1224-6_12
Torabi, S., Joharchi, K., Kalhori, K. A. M., Sohrabi, M., & Fekrazad, R. (2021). Evaluation of antimicrobial photodynamic therapy on wounds infected by Staphylococcus aureus in animal models. Photodiagnosis and Photodynamic Therapy. https://doi.org/10.1016/j.pdpdt.2020.102092
Kovács, K. (2019). Laser photodynamic therapy procedures. In C. J. Winkler (Ed.), Laser surgery in veterinary medicine. Hoboken: Wiley. https://doi.org/10.1002/9781119486053.ch16
Olarte, J., & De la Torre, J. A. (1959). Resistance of Shigella flexneri to tetracyclines, chloramphenicol and streptomycin; a study of 131 freshly isolated strains. American Journal of Tropical Medicine and Hygiene, 8(3), 324–326. https://doi.org/10.4269/ajtmh.1959.8.324
Cox, G., & Wright, G. D. (2013). Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions. International Journal of Medical Microbiology, 303(6–7), 287–292. https://doi.org/10.1016/j.ijmm.2013.02.009
Guerin, E., Cambray, G., Sanchez-Alberola, N., Campoy, S., Erill, I., Da Re, S., Gonzalez-Zorn, B., Barbé, J., Ploy, M. C., & Mazel, D. (2009). The SOS response controls integron recombination. Science, 324(5930), 1034. https://doi.org/10.1126/science.1172914
Guerin, E., Cambray, G., Da Re, S., Mazel, D., & Ploy, M. C. (2010). Les antibiotiques induisent la capture de gènes de résistance par les bactéries [The SOS response controls antibiotic resistance by regulating the integrase of integrons]. Medicine Science (Paris), 26(1), 28–30. https://doi.org/10.1051/medsci/201026128
Lerminiaux, N. A., & Cameron, A. D. S. (2019). Horizontal transfer of antibiotic resistance genes in clinical environments. Canadian Journal of Microbiology, 65(1), 34–44. https://doi.org/10.1139/cjm-2018-0275
Aminov, R. I., & Mackie, R. I. (2007). Evolution and ecology of antibiotic resistance genes. FEMS Microbiology Letters, 271(2), 147–161. https://doi.org/10.1111/j.1574-6968.2007.00757.x
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., & Tomasz, A. (2007). Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proceedings of the National Academy of Sciences, 104(22), 9451–9456. https://doi.org/10.1073/pnas.0609839104
Smitten, K., Fairbanks, S., Robertson, C., de la Serna, J. B., Foster, S., & Thomas, J. (2019). Ruthenium based antimicrobial theranostics—Using nanoscopy to identify therapeutic targets and resistance mechanisms in Staphylococcus aureus. Chemical Science. https://doi.org/10.1039/C9SC04710G
PHE. (2020). COVID-19: Infection prevention and control guidance June 2020. GW-1250.
PHE. (2021). COVID-19: Guidance for maintaining services within health and care settings. Infection prevention and control recommendations. GW-1659.
Villani, F. A., Aiuto, R., Paglia, L., & Re, D. (2020). COVID-19 and dentistry: Prevention in dental practice, A literature review. International Journal of Environmental Research and Public Health, 17(12), 4609. https://doi.org/10.3390/ijerph17124609
Azuma, K., Yanagi, U., Kagi, N., Kim, H., Ogata, M., & Hayashi, M. (2020). Environmental factors involved in SARS-CoV-2 transmission: Effect and role of indoor environmental quality in the strategy for COVID-19 infection control. Environmental Health Prevention Medicine, 25(1), 66. https://doi.org/10.1186/s12199-020-00904-2
Hsu, J. (2020). How covid-19 is accelerating the threat of antimicrobial resistance. BMJ, 369, m1983. https://doi.org/10.1136/bmj.m1983
Clancy, C. J., & Nguyen, M. H. (2020). Coronavirus disease 2019, superinfections, and antimicrobial development: What can we expect? Clinical Infection Disease, 71(10), 2736–2743. https://doi.org/10.1093/cid/ciaa524
Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews: MMBR, 74(3), 417–433. https://doi.org/10.1128/MMBR.00016-10
Novickij, V., Zinkevičienė, A., Perminaitė, E., et al. (2018). Non-invasive nanosecond electroporation for biocontrol of surface infections: An in vivo study. Scientific Reports, 8, 14516. https://doi.org/10.1038/s41598-018-32783-7
Lei, J., Sun, L., Huang, S., Zhu, C., Li, P., He, J., Mackey, V., Coy, D. H., & He, Q. (2019). The antimicrobial peptides and their potential clinical applications. American Journal of Translational Research, 11(7), 3919–3931.
Abdel-kader, M. H. (2016). The journey of PDT throughout history: PDT from Pharos to present chapter. In H. Kostron & T. Hasan (Eds.), Photodynamic medicine: From bench to clinic. Royal Society of Chemistry.
Huang, X., El-Sayed, I. H., Qian, W., & El-Sayed, M. A. (2006). Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. Journal of the American Chemical Society, 128(6), 2115–2120. https://doi.org/10.1021/ja057254a
Vatansever, F., de Melo, W. C., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., Tegos, G. P., & Hamblin, M. R. (2013). Antimicrobial strategies centered around reactive oxygen species—Bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiology Reviews, 37(6), 955–989. https://doi.org/10.1111/1574-6976.12026
Blaskovich, M. A. T., Kavanagh, A. M., Elliott, A. G., et al. (2021). The antimicrobial potential of cannabidiol. Communications Biology, 4, 7. https://doi.org/10.1038/s42003-020-01530-y
Steinstrasser, L., Lam, M. C., Jacobsen, F., Porporato, P. E., Chereddy, K. K., Becerikli, M., Stricker, I., Hancock, R. E., Lehnhardt, M., Sonveaux, P., Préat, V., & Vandermeulen, G. (2014). Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing. Molecular therapy: The journal of the American Society of Gene Therapy, 22(4), 734–742. https://doi.org/10.1038/mt.2013.258
Chen, C. H., & Lu, T. K. (2020). Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics, 9(1), 24. https://doi.org/10.3390/antibiotics9010024
Klausen, M., Ucuncu, M., & Bradley, M. (2020). Design of photosensitizing agents for targeted antimicrobial photodynamic therapy. Molecules, 25(22), 5239. https://doi.org/10.3390/molecules25225239
**e, S., Manuguri, S., Proietti, G., Romson, J., Fu, Y., Inge, A. K., Wu, B., Zhang, Y., Häll, D., Ramström, O., & Yan, M. (2017). Design and synthesis of theranostic antibiotic nanodrugs that display enhanced antibacterial activity and luminescence. Proceedings of the National Academy of Sciences of the United States of America, 114(32), 8464–8469. https://doi.org/10.1073/pnas.1708556114
Bullous, A. J. (2011). Photosensitiser–antibody conjugates for photodynamic therapy. Photochemical and Photobiological Sciences, 10, 721–750. https://doi.org/10.1039/C0PP00266F
Lehar, S., Pillow, T., Xu, M., et al. (2015). Novel antibody–antibiotic conjugate eliminates intracellular S. aureus. Nature, 527, 323–328. https://doi.org/10.1038/nature16057
Le, H., Arnoult, C., Dé, E., Schapman, D., Galas, L., Cerf, D. L., & Karakasyan, C. (2021). Antibody-conjugated nanocarriers for targeted antibiotic delivery: Application in the treatment of bacterial biofilms. Biomacromolecules. https://doi.org/10.1021/acs.biomac.1c00082
Huang, X., Neretina, S., & El-Sayed, M. A. (2009). Gold nanorods: From synthesis and properties to biological and biomedical applications. Advanced Materials, 21(48), 4880–4910.
Choi, S. K. (2020). Photo activation strategies for therapeutic release in nanodelivery systems. Advanced Therapeutics. https://doi.org/10.1002/adtp.202000117
Mammen, M., Choi, S. K., & Whitesides, G. M. (1998). Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angewandte Chemie (International ed in English), 37(20), 2754–2794. https://doi.org/10.1002/(SICI)1521-3773(19981102)37:20<2754::AIDANIE2754>3.0.CO;2-3.
Selvan, S. T., & Narayanan, K. (2016). Introduction to nanotheranostics (pp. 1–6). Singapore: Introduction to nanotheranostics. Springer. https://doi.org/10.1007/978-981-10-1008-8
Kirubakaran, N., Chandrika, M., & Reeta Vijaya Rani, K. (2015). Iontophoresis: Controlled transdermal drug delivery system. IJPSR, 6(8), 3174–3185. https://doi.org/10.13040/IJPSR.0975-8232
Rhodes, L. E., Tsoukas, M. M., Anderson, R. R., & Kollias, N. (1997). Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. Journal of Investigative Dermatology, 108(1), 87–91. https://doi.org/10.1111/1523-1747.ep12285644
Lepak, L. V. (2007). Chapter 7—Localized inflammation. In M. Cameron & L. G. Monroe (Eds.), Physical rehabilitation (pp. 117–139). Philadelphia: W.B. Saunders. https://doi.org/10.1016/B978-072160361-2.50010-7
Mizutani, K., Watanabe, D., Akita, Y., Akimoto, M., Tamada, Y., & Matsumoto, Y. (2009). Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application. Photodermatology, Photoimmunology and Biomedicine. https://doi.org/10.1111/j.1600-0781.2009.00456.x
Tan, G. Z., Orndorff, P. E., & Shirwaiker, R. A. (2019). The ion delivery manner influences the antimicrobial efficacy of silver oligodynamic iontophoresis. Journal of Medical and Biological Engineering, 39, 622–631. https://doi.org/10.1007/s40846-018-0447-1
Fish, R. M., & Geddes, L. A. (2009). Conduction of electrical current to and through the human body: A review. Eplasty, 9, e44.
Cohen, D. K., & Lee, P. K. (2016). Photodynamic therapy for non-melanoma skin cancers. Cancers, 8(10), 90. https://doi.org/10.3390/cancers8100090
Mackay, A. M., Brown, M. C., Hagan, R. P., et al. (2007). Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy. Documenta Ophthalmologica, 115, 69–76. https://doi.org/10.1007/s10633-007-9056-y
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. (1999). Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP report 1. Archives Ophthalmology, 117, 1329–1345.
Tang, G., Hyman, S., John, H., Schneider, M. D., Jr., Steven, L., & Giannotta, M. D. (1993). Application of photodynamic therapy to the treatment of atherosclerotic plaques. Neurosurgery, 32(3), 438–443. https://doi.org/10.1227/00006123-199303000-00016
Gallardo-Villagrán, M., Leger, D. Y., Liagre, B., & Therrien, B. (2019). Photosensitizers used in the photodynamic therapy of rheumatoid arthritis. International Journal of Molecular Sciences, 20(13), 3339. https://doi.org/10.3390/ijms20133339
Barr, H. (2000). Barrett’s esophagus: Treatment with 5-aminolevulinic acid photodynamic therapy. Gastrointestinal Endoscopy Clinics of North America, 10(3), 421–437. https://doi.org/10.1016/S1052-5157(18)30114-4
Boehncke, W. H. (2001). Chapter 16 Topical photodynamic therapy for psoriasis. In P. Calzavara-Pinton, R. M. Szeimies, & B. Ortel (Eds.), Comprehensive series in photosciences (Vol. 2, pp. 259–270). Oxford: Elsevier. https://doi.org/10.1016/S1568-461X(01)80120-4
Jenkins, M. P., Buonaccorsi, G. A., Raphael, M., Nyamekye, I., McEwan, J. R., Bown, S. G., & Bishop, C. C. R. (1999). Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. British Journal of Surgery, 86, 1258–1263. https://doi.org/10.1046/j.1365-2168.1999.01247.x
Hamblin, M. R., & Hasan, T. (2004). Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology, 3(5), 436–450. https://doi.org/10.1039/b311900a
Hamblin, M. R. (2016). Antimicrobial photodynamic inactivation: A bright new technique to kill resistant microbes. Current Opinion in Microbiology, 33, 67–73. https://doi.org/10.1016/j.mib.2016.06.008
Ivanova, V. A., Verenikina, E. V., Nikitina, V. P., Zhenilo, O. E., Kruze, P. A., Nikitin, I. S., & Kit, O. I. (2020). Photodynamic therapy for preinvasive cervical cancer. Journal of Clinical Oncology, 38(15 suppl), 6035–6035.
Nesi-Reis, V., Lera-Nonose, D., Oyama, J., Silva-Lalucci, M., Demarchi, I. G., Aristides, S., Teixeira, J., Silveira, T., & Lonardoni, M. (2018). Contribution of photodynamic therapy in wound healing. Photodiagnosis and Photodynamic Therapy, 21, 294–305. https://doi.org/10.1016/j.pdpdt.2017.12.015
Robertson, C. A., Evans, D. H., & Abrahamse, H. (2009). Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. Journal of Photochemistry and Photobiology B: Biology, 96(1), 1–8. https://doi.org/10.1016/j.jphotobiol.2009.04.001
Richter, A. M., Jain, A. K., Canaan, A. J., Waterfield, E., Sternberg, E., & Levy, J. G. (1992). Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring a (BPD-MA). Biochemical Pharmacology, 43(11), 2349–2358. https://doi.org/10.1016/0006-2952(92)90313-8
Yanka, D., et al. (2021). Photodynamic optimization by combination of xanthene dyes on different forms of Streptococcus mutans: An in vitro study. Photodiagnosis and Photodynamic Therapy, 33, 102191.
Aaron, J. J., Gaye Seye, M. D., Trajkovska, S., & Motohashi, N. (2008). Bioactive phenothiazines and benzo[a]phenothiazines: Spectroscopic studies, and biological and biomedical properties and applications. In N. Motohashi (Ed.), Bioactive heterocycles VII. Topics in heterocyclic chemistry. (Vol. 16). Springer. https://doi.org/10.1007/7081_2008_125
Kasimova, K. R., Sadasivam, M., Landi, G., Sarna, T., & Hamblin, M. R. (2014). Potentiation of photoinactivation of Grampositive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology, 13(11), 1541–1548. https://doi.org/10.1039/c4pp00021h
Yin, R., Wang, M., Huang, Y. Y., Landi, G., Vecchio, D., Chiang, L. Y., & Hamblin, M. R. (2015). Antimicrobial photodynamic inactivation with decacationic functionalized fullerenes: Oxygen independent photokilling in presence of azide and new mechanistic insights. Free Radical Biology and Medicine, 79, 14–27. https://doi.org/10.1016/j.freeradbiomed.2014.10.514
Wu, H., Zeng, F., Zhang, H., Xu, J., Qiu, J., & Wu, S. (2016). A nanosystem capable of releasing a photosensitizer bioprecursor under two-photon irradiation for photodynamic therapy. Advancement of Science, 3, 1500254. https://doi.org/10.1002/advs.201500254
Bennewitz, A., Prinz, M., & Wollina, U. (2013). Photodynamic therapy to improve wound healing in acute and chronic wounds: Tricylic dye combined with low level 810 nm diode laser irradiation. Kosmetische Medizin, 34, 208–215.
Morley, S., et al. (2013). Phase IIa randomized, placebo-controlled study of antimicrobial photodynamic therapy in bacterially colonized, chronic leg ulcers and diabetic foot ulcers: A new approach to antimicrobial therapy. British Journal of Dermatology, 168(3), 617–624. https://doi.org/10.1111/bjd.12098
Krupka, M., Bozek, A., Bartusik-Aebisher, D., Cieslar, G., & Kawczyk-Krupka, A. (2021). Photodynamic therapy for the treatment of infected leg ulcers—A pilot study. Antibiotics, 10, 506. https://doi.org/10.3390/antibiotics10050506
Gordois, A., Scuffham, P., Shearer, A., Oglesby, A., & Tobian, J. A. (2003). The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care, 26(6), 1790–1795. https://doi.org/10.2337/diacare.26.6.1790
Crawford, F., Nicolson, D. J., Amanna, A. E., et al. (2020). Preventing foot ulceration in diabetes: Systematic review and meta-analyses of RCT data. Diabetologia, 63, 49–64. https://doi.org/10.1007/s00125-019-05020-7
Karabanow, A. B., Zaimi, I., Suarez, L. B., Iafrati, M. D., & Allison, G. M. (2021). An analysis of guideline consensus for the prevention, diagnosis and management of diabetic foot ulcers. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/19-175
Mookherjee, N., Anderson, M. A., Haagsman, H. P., et al. (2020). Antimicrobial host defence peptides: Functions and clinical potential. Nature Reviews Drug Discovery, 19, 311–332. https://doi.org/10.1038/s41573-019-0058-8
Bormann, N., Koliszak, A., Kasper, S., Schoen, L., Hilpert, K., Volkmer, R., Kikhney, J., & Wildemann, B. (2017). A short artificial antimicrobial peptide shows potential to prevent or treat bone infections. Scientific Reports, 7(1), 1506. https://doi.org/10.1038/s41598-017-01698-0
Bopari, J. K., et al. (2020). Mini review on antimicrobial peptides, sources, mechanism and recent applications. Protein and Peptide Letters, 27(1), 4–16. https://doi.org/10.2174/0929866526666190822165812
Ashby, M., Petkova, A., Gani, J., Mikut, R., & Hilpert, K. (2017). Use of peptide libraries for identification and optimization of novel antimicrobial peptides. Current Topics in Medicinal Chemistry, 17(5), 537–553. https://doi.org/10.2174/1568026616666160713125555
Kang, X., Dong, F., Shi, C., Liu, S., Sun, J., Chen, J., Li, H., Xu, H., Lao, X., & Zheng, H. (2019). DRAMP 2.0, an updated data repository of antimicrobial peptides. Scientific Data, 6(1), 148. https://doi.org/10.1038/s41597-019-0154-y
Ayaz, M., Subhan, F., Ahmed, J., Khan, A., Ullah, F., Sadiq, A., Syed, N.-i-H., Ullah, I., & Hussain, S. (2015). Citalopram and venlafaxine differentially augments antimicrobial properties of antibiotics. Acta Poloniae Pharmaceutica, 72, 1269–1278.
**, M., Lu, J., Chen, Z., Nguyen, S. H., Mao, L., Li, J., Yuan, Z., & Guo, J. (2018). Antidepressant fluoxetine induces multiple antibiotics resistance in Escherichia coli via ROS-mediated mutagenesis. Environment International, 120, 421–430. https://doi.org/10.1016/j.envint.2018.07.046
Morton, C. A., Brown, S. B., Collins, S., Ibbotson, S., Jenkinson, H., Kurwa, H., Langmack, K., McKenna, K., Moseley, H., Pearse, A. D., Stringer, M., Taylor, D. K., Wong, G., & Rhodes, L. E. (2002). Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. The British Journal of Dermatology, 146(4), 552–567.
Morton, C. A., McKenna, K. E., Rhodes, L. E., & British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. (2008). Guidelines for topical photodynamic therapy: Update. The British Journal of Dermatology, 159(6), 1245–1266. https://doi.org/10.1111/j.1365-2133.2008.08882.x
Aguayo-Albasini, J. L., Flores-Pastor, B., & Soria-Aledo, V. (2014). Sistema GRADE: Clasificacio´n de la calidad de la evidencia y graduacio´n de la fuerza de la recomendacio´ n. Cirugía Española, 92, 82–88.
Morton, C. A., Szeimies, R.-M., Sidoroff, A., & Braathen, L. R. (2012). European guidelines for topical photodynamic therapy part 2: Emerging indications—Field cancerization, photorejuvenation and inflammatory/infective dermatoses. Journal of the European Academy of Dermatology and Venereology: JEADV. https://doi.org/10.1111/jdv.12026
Sakamoto, F. H., Lopes, J. D., & Anderson, R. R. (2010). Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: Part I. Acne vulgaris: When and why consider photodynamic therapy? Journal of the American Academy of Dermatology, 63(2), 183–194. https://doi.org/10.1016/j.jaad.2009.09.056
Smucler, R., & Jatsová, E. (2005). Comparative study of aminolevulic acid photodynamic therapy plus pulsed dye laser versus pulsed dye laser alone in treatment of viral warts. Photomedicine and Laser Surgery, 23, 202–205. https://doi.org/10.1089/pho.2005.23.202
Enk, C. D., Fritsch, C., Jonas, F., Nasereddin, A., Ingber, A., Jaffe, C. L., & Ruzicka, T. (2003). Treatment of cutaneous leishmaniasis with photodynamic therapy. Archives of Dermatology, 139(4), 432–434. https://doi.org/10.1001/archderm.139.4.432
Morton, C., et al. (2019). European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: Emerging indications—Field cancerization, photorejuvenation and inflammatory/infective dermatoses. Journal of the European Academy of Dermatology and Venereology: JEADV. https://doi.org/10.1111/jdv.16044
Wiegell, S. R., & Wulf, H. C. (2006). Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. Journal of the American Academy of Dermatology, 54(4), 647–651. https://doi.org/10.1016/j.jaad.2005.12.033
Kim, T. I., Ahn, H.-J., Kang, I. H., Jeong, K.-H., Kim, N. I., & Shin, M. K. (2017). Nonablative fractional laser-assisted daylight photodynamic therapy with topical methyl aminolevulinate for moderate to severe facial acne vulgaris: Results of a randomized and comparative study. Photodermatology, Photoimmunology and Photomedicine, 33, 253–259. https://doi.org/10.1111/phpp.12312
Wang, Y. S., Tay, Y. K., Kwok, C., & Tan, E. (2007). Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population. International Journal of Dermatology, 46, 1180–1184. https://doi.org/10.1111/j.1365-4632.2007.03210.x
Chen, K., Chang, B., Ju, M., Zhang, X., & Gu, H. (2007). Comparative study of photodynamic therapy vs. CO2 laser vaporization in treatment of condylomata acuminata, a randomized clinical trial. British Journal of Dermatology, 156, 516–520. https://doi.org/10.1111/j.1365-2133.2006.07648.x
Sainz-Gaspar, L., Rosón, E., Llovo, J., & Vázquez-Veiga, H. (2019). Photodynamic therapy in the treatment of cutaneous leishmaniasis. Terapia fotodinámica en el tratamiento de la leishmaniasis cutánea. Actas Dermo-Sifiliograficas, 110(3), 249–251. https://doi.org/10.1016/j.ad.2018.02.018
Enk, C., Nasereddin, A., Alper, R., Dan-Goor, M., Jaffe, C., & Wulf, H. (2015). Cutaneous leishmaniasis responds to daylightactivated photodynamic therapy: Proof of concept for a novel selfadministered therapeutic modality. British Journal of Dermatology, 172, 1364–1370. https://doi.org/10.1111/bjd.13490
Souza, L. W., Figueiredo, S., Trancoso, S. V., Botelho, A. C., & de Carvalho. (2014). Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: Treatment with photodynamic therapy based on methylene blue dye. Anais Brasileiros de Dermatologia, 89(1), 184–186. https://doi.org/10.1590/abd1806-4841.20142197
Wong, T., Morton, C., Collier, N., Haylett, A., Ibbotson, S., McKenna, K., Mallipeddi, R., Moseley, H., Seukeran, D., Rhodes, L., Ward, K., Mohd Mustapa, M., & Exton, L. (2019). British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018. British Journal of Dermatology, 180, 730–739. https://doi.org/10.1111/bjd.17309
NICE guideline Acne Vulgaris (pending)
Eady, E. A., Bojar, R. A., Jones, C. E., Cove, J. H., Holland, K. T., & Cunliffe, W. J. (1996). The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin resistant propionibacteria. British Journal of Dermatology, 134, 107–113. https://doi.org/10.1046/j.1365-2133.1996.d01-733.x
Walsh, T. R., Efthimiou, J., & Dréno, B. (2016). Systematic review of antibiotic resistance in acne: An increasing topical and oral threat. The Lancet Infectious diseases, 16(3), e23–e33. https://doi.org/10.1016/S1473-3099(15)00527-7
NICE MTG 2019 Urgostart dressings. https://www.nice.org.uk/guidance/mtg42
Baker, N., & Osman, I. (2016). The principles and practicalities of offloading diabetic foot ulcers. The Diabetic Foot Journal, 19(4), 172–181.
Ambulight PDT for the treatment of non-melanoma skin cancer. https://www.nice.org.uk/guidance/mtg6
WHO. World Action Plan on Antimicrobial Resistance. 2015. https:// WHA68/2015/REC/1, Annex 3
Mohid, S. A., & Bhunia, A. (2020). Combining antimicrobial peptides with nanotechnology: An emerging field in theranostics. Current Protein and Peptide Science, 21(4), 413–428. https://doi.org/10.2174/1389203721666191231111634
Chitgupi, U., Qin, Y., & Lovell, J. F. (2017). Targeted nanomaterials for phototherapy. Nanotheranostics, 1(1), 38–58. https://doi.org/10.7150/ntno.17694
Jagtap, P., Sritharan, V., & Gupta, S. (2017). Nanotheranostic approaches for management of bloodstream bacterial infections. Nanomedicine: Nanotechnology, Biology, and Medicine, 13(1), 329–341. https://doi.org/10.1016/j.nano.2016.09.005
Merchat, M., Spikes, J. D., Bertoloni, G., & Jori, G. (1996). Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. Journal of Photochemistry and Photobiology B, Biology, 35(3), 149–157.
Ng, D. K. (2014). Phthalocyanine-based photosensitizers: More efficient photodynamic therapy? Future Medicinal Chemistry, 6(18), 1991–1993.
Ibbotson, S. H. (2002). Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. The British Journal of Dermatology, 146(2), 178–188.
De Annunzio, S. R., Costa, N., Mezzina, R. D., Graminha, M., & Fontana, C. R. (2019). Chlorin, phthalocyanine, and porphyrin types derivatives in phototreatment of cutaneous manifestations: A review. International Journal of Molecular Sciences, 20(16), 3861.
Yin, R., & Hamblin, M. R. (2015). Antimicrobial photosensitizers: Drug discovery under the spotlight. Current Medicinal Chemistry, 22(18), 2159–2185.
Wilson, M., & Mia, N. (1993). Sensitisation of Candida albicans to killing by low-power laser light. Journal of Oral Pathology and Medicine: Official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 22(8), 354–357. https://doi.org/10.1111/j.1600-0714.1993.tb01088.x
Noimark, S., Salvadori, E., Gómez-Bombarelli, R., MacRobert, A. J., Parkin, I. P., & Kay, C. W. (2016). Comparative study of singlet oxygen production by photosensitiser dyes encapsulated in silicone: Towards rational design of anti-microbial surfaces. Physical Chemistry Chemical Physics: PCCP, 18(40), 28101–28109.
Nardini, E. F., Almeida, T. S., Yoshimura, T. M., Ribeiro, M. S., Cardoso, R. J., & Garcez, A. S. (2019). The potential of commercially available phytotherapeutic compounds as new photosensitizers for dental antimicrobial PDT: A photochemical and photobiological in vitro study. Photodiagnosis and Photodynamic Therapy, 27, 248–254.
Delaey, E., van Laar, F., De Vos, D., Kamuhabwa, A., Jacobs, P., & de Witte, P. (2000). A comparative study of the photosensitizing characteristics of some cyanine dyes. Journal of Photochemistry and Photobiology B: Biology, 55(1), 27–36.
Tegos, G. P., Demidova, T. N., Arcila-Lopez, D., Lee, H., Wharton, T., Gali, H., et al. (2005). Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol, 12(10), 1127–1135. https://doi.org/10.1016/j.chembiol.2005.08.014
Baier, J., Maisch, T., Maier, M., Engel, E., Landthaler, M., & Bäumler, W. (2006). Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. Biophys J, 91(4), 1452–1459. https://doi.org/10.1529/biophysj.106.082388.
Maisch, T., Eichner, A., Späth, A., Gollmer, A., König, B., Regensburger, J., et al. (2014). Fast and effective photodynamic inactivation of multiresistant bacteria by cationic riboflavin derivatives. PLoS One, 9(12), e111792. https://doi.org/10.1371/journal.pone.0111792.
Yang, Q. Q., Farha, A. K., Kim, G., Gul, K., Gan, R. Y., & Corke, H. (2020). Antimicrobial and anticancer applications and related mechanisms of curcumin-mediated photodynamic treatments. Trends in Food Science and Technology, 97, 341–354. https://doi.org/10.1016/j.tifs.2020.01.023
Acknowledgements
The author would like to thank Ms. Kari O’Neill, Mr. Robert Bolton, and Mr. Andrew Gardner for their support during a challenging period in the UK NHS, and Professor Lesley Rhodes for her comments on the manuscript.
Funding
The author did not receive financial support from any organization for the submitted work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author has no conflicts of interest to disclose.
Ethical approval
Ethics approval was not required as we did not recruit subjects to this review.
Consent to participate
Consent to participate was not required as there were no subjects in this review.
Consent to publish
Consent to publish was not required as there were no patients in this review.
Rights and permissions
About this article
Cite this article
Mackay, A.M. The evolution of clinical guidelines for antimicrobial photodynamic therapy of skin. Photochem Photobiol Sci 21, 385–395 (2022). https://doi.org/10.1007/s43630-021-00169-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43630-021-00169-w